New hope for Parkinson's pain: trial tests potential relief drug
NCT ID NCT07483398
Summary
This study is testing whether a medication called Crisugabalin can safely reduce chronic pain in people with Parkinson's disease. Researchers will compare 166 participants taking either Crisugabalin or a placebo (inactive pill) for 12 weeks to see which group experiences better pain relief and improved quality of life. The trial focuses specifically on patients whose pain is linked to their Parkinson's and has been stable for at least three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE WITH NOCICEPTIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
No. 106 Zhongshan Er Road
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.